Runnymede Capital Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,782	Closed	-$145K	–	274
2025 Q1	$145K	Hold	1,782	–	–	0.14%	83
2024 Q4	$160K	Buy	+1,782	New	+$160K	0.14%	82